Table 2.

Tumor assessment (RECIST best response)

Best RECIST response	All patients (n = 19)
Assessment of best response
Complete response (%)	0
Confirmed partial response (%)	3 (16)
Stable disease 24 wk or longer (%)	10 (53)
Stable disease 8 wk or longer, less than 24 wk (%)	2 (11)
Progressive disease (%)	3 (16)
Not evaluable (%)	1 (5)
Objective response rate (CR + PR) (%) (95% CI)	16 (3.4–39.6)
Disease control rate (CR + PR + SD ≥ 24 wk) (%) (95% CI)	68 (43.4–87.4)

CI, Confidence interval; CR, complete response; PR, partial response; SD, stable disease.